Month 2016
Simple and Convenient Method for the Synthesis of 3,5-disubstituted 1,2,4-
Thiadiazoles via Oxidative Dimerization of Primary Thioamides
and DMSO-d6 (δH =2.50ppm, δc =39.52ppm) were used as
internal standards. Elemental analyses were performed on an
Elementar Vario EL microanalyzer. Low-resolution mass
spectra (ESI-MS) and HRMS were recorded on Quattro
LC, Micromass, and Q STAR XL, Applied Biosystems, re-
spectively. Column chromatography was performed using
silica gel (Acme’s 60–120mesh). Solvents for chromatogra-
phy (n-hexane, acetonitrile, cyclohexane, and EtOAc) were
distilled prior to use. For analytical thin-layer chromatogra-
phy, Merck pre-coated silica gel 60F-254 plates were used;
the plates were visualized using UV light (254nm) or iodine
vapor or by dipping the plates in phosphomolybdic acid ceric
(IV)sulfate-sulphuric acid (PMA) solution and heating the
plates at 100°C.
1465, 1406, 1321, 1110, 839, 709 cmÀ1 1H NMR
;
(300 MHz, CDCl3): δ 8.32 (d, J = 8.6 Hz, 2H), 7.98 (d,
J = 8.6 Hz, 2H), 7.61–7.46 (m, 4H), 1.39 (S, 18H); 13C
NMR (75 MHz, DMSO-d6): δ 165.4, 152.2, 150.3,
140.75, 120.4, 111.0, 107.3, 56.5, 56.4, 53.0. HRMS:
Calcd. for C22H26N2S = 351.1889 [M + H]+. Found:
351.1886.
3,5-Bis(4-methylphenyl)-1,2,4-thiadiazole (2d).
White
solid, mp 129–130°C (lit.18 135–137°C); IR (KBr) νmax
3040, 2957, 2863, 1605, 1475, 1406, 1321, 1110, 839,
709cmÀ1 1H NMR (300MHz, CDCl3): δ 8.29 (d,
:
;
J=8.2Hz, 2H), 7.94 (d, J=8.2Hz, 2H), 7.35–7.24 (m,
4H), 2.43 (s, 3H); 13C NMR (CDCl3): δ 187.9, 173.7,
142.4, 140.4, 130.3, 129.8, 129.3, 128.2, 127.4, 21.6, 21.5.
HRMS: Calcd for C16H14N2S=267.0950. Found: 267.0946.
General procedure for the synthesis of 3,5-disubstituted
1,2,4-thiadiazoles [29]. To a stirred solution of arylthioamide
(5.0 mmol) in water (0.5mL) at room temperature was
added TCCA (3.88 g, 1.67mmol) in one portion. The color
of the reaction solution changed to yellow at the beginning
of the reaction and it was disappeared after few seconds.
The reaction mixture was stirred magnetically at room
temperature for the specified time (Table 1) until
arylthioamide was completely disappeared (the progress of
the reaction was monitored by thin-layer chromatography).
After completion of the reaction, the reaction mixture was
extracted with ethyl acetate (3 ×5mL) followed by brine
(5mL). The organic layer was dried over anhy.Na2SO4 and
concentrated under reduced pressure to give crude product,
which was purified by silica gel column chromatography
using petroleum ether and ethyl acetate (95:5) to afford
analytically pure substituted thiadiazoles in 82–96% yield.
3,5-Bis(3-chlorolphenyl)-1,2,4-thiadiazole (2g).
White
solid, mp 125–127°C; IR (KBr) νmax: 3046, 2950, 2863,
1605, 1470, 1406, 1321, 1110, 839, 709 cmÀ1; H NMR
1
(300 MHz, CDCl3): δ 8.41 (d, J = 1.8 Hz, 1H), 8.28 (dd,
J = 7.0 Hz, 1H), 8.09 (d, J = 1.9 Hz, 1H), 7.92 (d,
J = 7.5 Hz, 1H), 7.57–7.43 (m, 4H); 13C NMR (CDCl3): δ
186.9, 172.5, 135.4, 134.7, 134.2, 131.9, 130.6, 130.5,
130.0, 128.5, 127.3, 126.4, 125.6; ESI MS: m/z 307 [M
+ H]+. Anal. Calcd. for C14H8Cl2N2S: C, 54.74; H, 2.61;
N, 9.12; S, 10.45. Found: C, 54.68; H, 4.22.61; N, 9.10;
S, 10.43.
3,5-Bis(4-nitrophenyl)-1,2,4-thiadiazole (2i). Pale yellow
solid, mp 201–202°C (lit.16 198–199°C); IR (KBr) νmax
:
3075, 2950, 2863, 1605, 1535, 1470, 1406, 1321, 839,
709 cmÀ1 1H NMR (300MHz, CDCl3): δ 8.60 (d,
;
J = 8.2 Hz, 1H), 8.45–8.33 (m, 4H), 8.25 (d, J =8.2 Hz,
1H), 7.88 (d, J = 8.2 Hz, 2H); 13C NMR (CDCl3): δ
191.5, 169.5, 157.1, 154.8, 152.9, 148.7, 147.9, 144.2,
143.7, 143.5, 137.8, 136.2; ESI MS: m/z 328 [M +H]+.
Anal. Calcd. for C14H8N4O4S: C, 51.22; H, 2.46; N,
17.07; S, 9.77. Found: C, 51.25; H, 2.42; N, 17.02; S, 9.81.
3,5-Bis(5-bromofuran-2-yl)-1,2,4-thiadiazole (2j). White
solid, mp 185–186°C; IR (KBr) νmax: 3060, 2965, 2863,
3,5-Diphenyl-1,2,4-thiadiazole (2a).
White solid, mp
90–91°C (lit.18 89–90°C); IR (KBr) νmax: 3045, 1590,
1475 cmÀ1 1H NMR (300 MHz, CDCl3): δ 8.45–8.38
;
(m, 2H), 8.12–8.04 (m, 2H), 7.60–7.48 (m, 6H); 13C
NMR (75 MHz, CDCl3): δ 188.0, 173.7, 132.8, 131.9,
130.6, 130.3, 129.2, 128.6, 128.3, 127.4; ESI MS: m/z
239 [M + H]+. Anal. Calcd. for C14H10N2S: C, 70.56; H,
4.23; N, 11.76; S, 13.46. Found: C, 70.59; H, 4.24; N,
11.74; S, 13.44.
1605, 1535, 1470, 1406, 1321, 839, 709 cmÀ1; H NMR
1
(300 MHz, CDCl3): δ 7.22 (d, J = 3.6 Hz, 1H), 7.16 (d,
J = 3.5 Hz, 1H), 6.57 (d, J = 3.6 Hz, 1H), 6.50 (d,
J = 3.5 Hz, 1H); 13C NMR (CDCl3): δ 175.9, 149.7,
126.9, 125.2, 115.1, 114.9, 114.8, 113.8; ESI MS: m/z
376 [M + H]+. Anal. Calcd. for C10H4Br2N2O2S: C,
31.94; H, 1.06; N, 7.45; S, 8.53. Found: C, 31.89; H,
1.02; N, 7.38; S, 8.48.
3,5-Bis(4-methoxyphenyl)-1,2,4-thiadiazole (2b). White
solid, mp 137–138°C (lit.18 139–140°C); IR (KBr) νmax
:
2923, 2851, 1607, 1579, 1519, 1475, 1419, 1307, 1275,
1
1250, 1168, 1027 cmÀ1. H NMR (300 MHz, CDCl3): δ
8.33 (d, J = 8.6 Hz, 2H), 7.98 (d, J = 8.6 Hz, 2H), 7.02
(d, J = 8.5 Hz, 4H), 3.89 (S, 6H); 13C NMR (75 MHz,
CDCl3): δ 187.3, 173.3, 162.4, 161.2, 129.8, 129.1,
126.0, 123.6, 114.5, 113.9, 55.5, 55.3. HRMS: Calcd.
3,5-Cyclohexylmethyl-1,2,4-thiadiazole (2m).
liquid; 1H NMR (300 MHz, CDCl3):
Colorless
δ 2.96 (d,
for
C16H14O2N2S = 299.0849
[M + H]+.
Found:
J = 6.5 Hz, 1H), 2.84 (d, J = 7.2 Hz, 1H), 1.74 (dt,
J = 18.3, 8.5 Hz, 10H), 1.37–0.93 (m, 12H), 1.39 (S,
18H); 13CNMR (75 MHz, CDCl3): δ 190.0, 176.4, 40.5,
38.7, 38.6, 37.4, 33.0, 32.9, 30.1, 29.6, 26.0, 25.9.
HRMS: Calcd. for C16H26N2S = 279.1889 [M + H]+.
Found: 279.1882.
299.0845. Anal. Calcd. for C16H14O2N2S: C, 63.98; H,
5.37; N, 9.33; S, 10.67. Found: C, 63.93; H, 5.36; N,
9.31; S, 10.69.
3,5-Bis(4-(t-butyl)phenyl)-1,2,4-thiadiazole (2c). White
solid, mp 91–92°C; IR (KBr) νmax: 2957, 2863, 1605,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet